Hrt Financial LP Pro Qr Therapeutics N.V. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.62 - $2.32 $242,695 - $347,563	-149,812 Reduced 87.45%	21,494 $34,000
Q1 2023 May 12, 2023	BUY	$1.99 - $3.66 $340,898 - $626,979	171,306 New	171,306 $364,000
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.0 $26,022 - $46,469	46,469 New	46,469 $36,000
Q1 2020 May 15, 2020	SELL	$5.25 - $9.9 $297,580 - $561,151	-56,682 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $331,022 - $595,727	56,682 New	56,682 $561,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $188M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.